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UbiquitinThe human BAP1 deubiquitinating enzyme is a chromatin-bound transcriptional regulator and
tumor suppressor. BAP1 functions in suppressing cell proliferation, yet its role in the DNA damage
response pathway is less understood. In this study we characterized DNA damage-induced phos-
phorylation of BAP1 at serine 592 (pS592) and the cellular outcomes of this modiﬁcation. In contrast
to the majority of BAP1, pS592-BAP1 is predominantly dissociated from chromatin. Our ﬁndings
support a model whereby stress induced phosphorylation functions to displace BAP1 from speciﬁc
promoters. We hypothesize that this regulates the transcription of a subset of genes involved in the
response to DNA damage.
Structured summary of protein interactions:
HCF-1 physically interacts with Bap1 by anti bait coimmunoprecipitation (1, 2)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The human BAP1 (BRCA1-Associated Protein 1) gene encodes a
729 amino acid deubiquitinating enzyme (DUB) that is nuclear
localized and chromatin-associated [1,2]. In the BAP1-null NCI-
H226 cell line BAP1 is a tumor suppressor [2], and in uveal mela-
noma (UM) BAP1 unequivocally adheres to the classical ‘two-hit’
tumor suppressor model [3]. Genetic studies have uncovered so-
matic BAP1 mutations in numerous cancers, and germline BAP1
mutations cause a cancer susceptibility disorder that predisposes
BAP1+/ individuals to multiple cancers (reviewed in [4]). The tu-
mor suppressor properties of BAP1 derive in part from its ability
to regulate cell cycle progression. Restoration of BAP1 inhibits cell
growth in cancer cell lines that lack BAP1 (NCI-H226 cells) or ex-
press defective BAP1(769-P cells) [2,5].
BAP1 is thought to function in transcriptional complexes where
it deubiquitinates proteins and co-regulates gene expression. The
best studied binding partner, HCF-1, is a transcriptional regulator
that functions with numerous transcription factors, assembling in
chromatin modifying complexes associated with both gene activa-
tion and repression (reviewed in [6,7]). BAP1, HCF-1 and the YY1
transcription factor form a ternary complex regulating gene expres-
sion [8], and it is reasonable to suspect similar complexes are
formed with other known transcription cofactors that are known
to bind BAP1 (such as FoxK1/2, ASXL1/2, CBX1/3, etc.) [8–10]. A
large fraction of BAP1 is bound to HCF-1 [5,9], and they co-occupy>3700 gene promoters in mice [11]. An intact BAP1/HCF-1 interac-
tion is required for BAP1-mediated growth suppression in the 769-
P clear cell renal cell carcinoma (ccRCC) line [5]. BAP1 deubiquiti-
nates poly-ubiquitinated HCF-1, yet depletion of BAP1 has shown
mixed effects on the stability of HCF-1 protein levels [5,9,11,12].
A second transcriptional complex is formed with a polycomb
group (PcG) protein ASXL1. The puriﬁed BAP1/ASXL1 complex
was shown to deubiquitinate Histone H2A but not Histone H2B
in reconstituted nucleosomes [13]. The drosophila orthologs of
BAP1 and ASXL1 (Calypso and ASX) co-localize to 879 genomic
sites, including the PcG target gene Ubx where the DUB activity
of Calypso was required for transcriptional repression [13]. Loss
of ASX in ﬂy embryos reduces Calypso levels and leads to a modest
increase in ubiquitinated Histone H2A levels [13]. Changes to ubiq-
uitin-Histone H2A levels have also been observed when BAP1 lev-
els are altered in human and mouse cancer cell lines [5,14]. The
BAP1/ASXL1 complex could be a critical component of hematopoi-
esis as ASXL1 mutations and dysfunction are linked to humanmye-
loproliferative and myelodysplastic disorders [15], and BAP1
knockout mice develop hematological features characteristic of
these diseases [11].
BAP1 has also been implicated in the cellular response to DNA
damage. Depletion of BAP1 using shRNA in HeLa cells led to re-
duced cell viability following exposure to ionizing radiation (IR)
[16]. A similar result was observed in two ccRCC cell lines that ex-
press mutant BAP1; restoration of WT BAP1 protected cells from
IR-induced cell death [5]. The loss of BAP1 does not inﬂuence the
formation of IR-induced double strand break repair foci in ccRCC
and mesothelioma cell lines [5,17], however the transcription of
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amongst those deregulated following BAP1 depletion [8]. Proteo-
mic studies have identiﬁed several sites of phosphorylation in
BAP1, including ﬁve serines within a ﬁfteen residue stretch (583,
592, 595, 596, and 597) that become modiﬁed after UV and/or IR
induced DNA damage [18–20]. One of these sites S592 conforms
to the canonical SQ/TQ motif recognized by the DNA damage acti-
vated phosphatidylinositol 3-kinase-related kinases ATM, ATR, and
DNA-PKcs [21]. Thus, evidence suggests a growth suppressive role
for BAP1 following DNA damage and post-translational modiﬁca-
tion by phosphorylation may mediate this effect.
In this study we sought to characterize BAP1 phosphorylation
and its role in DNA damage response (DDR) pathway.We have char-
acterized a commercially available antibody that recognizes BAP1
phosphorylated at S592 (pS592) and used it to probe the induction
of phosphorylation and subsequent outcomes following irradiation
with UV and exposure to other cellular stressors. Our ﬁndings show
that a small fraction of BAP1 is rapidly phosphorylated at S592 in S-
phase following replication stress. In contrast to bulk BAP1, the
majority of pS592-BAP1 is not associated with chromatin. We pro-
pose a model whereby phosphorylation at S592 is a regulatory
mechanism to dissociate BAP1 from chromatin and regulate speciﬁc
genes involved in DNA replication and repair.
2. Materials and methods
2.1. Cell culture and treatments
HeLa cells and NCI-H226 cells were purchased from American
Type Culture Collection. HeLa cells were cultured in DMEM while
NCI-H226 cells were cultured in RPMI-1640. Both media were sup-
plementedwith 10% heat-inactivated fetal bovine serum (Life Tech-
nologies), 100 U/mL penicillin, and 100 lg/mL streptomycin. Cells
were maintained in a humidiﬁed incubator at 37 C with 5% CO2.
For UV-treatment, cells were irradiated with the indicated dose
of UV-C (254 nm) using a Stratalinker 1800 (Stratagene). Cells were
washed with cold PBS, mock- or UV-treated, fed media, and al-
lowed to recover for the indicated times. Hydroxyurea was added
to media at a ﬁnal concentration of 2 mM for 3 h or the indicated
times. HeLa cells were treated with 1 mM methyl methanesulfo-
nate, 0.5 mM sodium arsenite, or 0.125 mM H2O2 for 1 h before
recovering in fresh media for 3 h prior to harvesting.
2.2. Antibodies
Antibodies used for immunoblots: BAP1 (Santa Cruz, sc-28383),
pS592-BAP1 (Cell Signaling, #9373), ubiquitinated-Histone H2A
(Cell Signaling, #8240),MEK1 (Bethyl, A302-140A), VCP (Cell Signal-
ing #2648), and Actin (Sigma, A3853). Antibodies used in IPs: BAP1
(Bethyl, A302-243A), normal rabbit IgG (Santa Cruz, sc-2027). The
HCF-1 antibody was used in IPs and IBs (Bethyl, A301-399A).
2.3. Plasmids and transfections
The BAP1 cDNAwas subcloned into the pcDNA4 expression vec-
tor, and a modiﬁed pcDNA4 plasmid encoding an N-terminal Flag-
HA epitope tag. The S592A mutation was made using overlapping
PCR. Wild type and mutant BAP1 genes were conﬁrmed by DNA
sequencing. HeLa cells were transfected with pcDNA4-Flag-HA-
BAP1 vectors using Lipofectamine-2000 (Life Technologies) for
24 h according to the manufacturer’s protocol.
2.4. Cell lysis and fractionations
Soluble cell extracts (SCEs) were prepared by resuspending cell
pellets in 1 mL/106 cells of NP40 lysis buffer [50 mM Tris (pH 7.5),150 mM NaCl, 0.5% Nonidet P40, protease inhibitor cocktail (Com-
plete EDTA-free, Roche), phosphatase inhibitor cocktail (PhosStop,
Roche)]. Lysates were allowed to rotate at 4 C for 1 h before cen-
trifuging at 16000g to recover the SCE. The insoluble material
(IM) was resuspended in 2 SDS–PAGE gel loading buffer and son-
icated with a microtip (Misonix) using two 5 s pulses and an out-
put of 3.
Cellular fractionations were performed at 4 C according to a
previously described method [22]. For salt extractions of chroma-
tin, hypotonic buffer supplemented with indicated amounts of
NaCl was used to sequentially extract the P2 pellet by iteratively
incubating for 10 min and centrifuging at 16000g. The P1 and
P2 chromatin-containing fractions were resuspended in 2
SDS–PAGE gel loading buffer and sonicated. SCEs and the S1 sam-
ples from fractionations were quantitated using the Bio-Rad pro-
tein assay. For Western blot analysis, 20 lg of SCEs or S1 fractions
and an equal percentage of other fraction (IM, P1, S2, or P2) were
separated by SDS–PAGE and transferred to nitrocellulose or PVDF
membranes.
2.5. Immunoprecipitations
IP of endogenous proteins were performed using 0.3 mg of
HeLa SCE, 10 lL of protein A dynabeads (Invitrogen) and
2.5 lg of antibody (except HCF-1, 1.25 lg). Antibody-bound dyn-
abeads were incubated with whole cell extracts overnight at
4 C. Beads were was three times with NP40 lysis buffer, two
times with PBS and bound proteins were eluted with 2 SDS–
PAGE gel loading buffer. Anti-Flag IPs were performed with
anti-Flag(M2) agarose (Sigma–Aldrich). SCEs (4 mg) were incu-
bated with 20 lL for 2 h at 4 C, washed three times with
NP40 lysis buffer, three times with PBS, and eluted seven times
with PBS + 250 lg/mL ﬂag peptide (Sigma–Aldrich). Eluates were
pooled prior to analysis.
2.6. Dephosphorylation reactions
Incubations with calf intestinal phosphatase (New England Bio-
Labs) were performed using SCEs according to the manufacturer’s
protocol for 30 min at 37 C.
2.7. Double thymidine block
HeLa cells were arrested in early S-phase using a double thy-
midine block. Cells were harvested at 2 h intervals following re-
lease from the second block. For UV-treatment of synchronized
cells, a parallel set of plates were treated with 1 mJ/cm2 UV at
the indicated times and allowed to recover 1 h prior to
harvesting.2.8. Flow cytometry
Harvested cells were washed with PBS and ﬁxed by resus-
pending in 0.5 mL PBS and adding 5 mL of 70% ethanol. Cells
were stained with propidium iodide: 0.5 mL of 2 mg/mL RNAase
(Sigma–Aldrich, R5125) and 0.5 mL propidium iodide solution
[PBS, 0.1 mg/mL propidium iodide, 0.6% Triton X-100]. Cells were
stained 1 h before passing through mesh-capped tubes (Falcon,
352235) and analyzing on a Becton–Dickson LSR II ﬂow cytome-
ter (20000–50000 events). Cell cycle analysis was performed
using FlowJo software. Gates were used to remove cell debris
(forward scatter-area vs. side scatter-area) and cell doublets
(propidium iodide-area vs. propidium iodide-width). The result-
ing histograms of propidium iodide-area were analyzed for cell
cycle distributions using the Watson Pragmatic Model.
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3.1. BAP1 is phosphorylated at Ser592 following UV irradiation
We assessed the levels of pS592-BAP1 in HeLa cells and the
BAP1-null non-small cell lung carcinoma cell line NCI-H226 [1,2]
using a commercially available anti-pS592-BAP1 antibody that
was raised against a phospho-peptide corresponding to the resi-
dues ﬂanking BAP1 S592. Western blots of soluble cell extracts
(SCEs) of mock- or UV-treated cells conﬁrmed that HeLa cells con-
tain BAP1 migrating with an apparent MW of 100 kDa, while NCI-
H226 cells do not (Fig. 1A). Under these lysis conditions [10], the
nuclear and chromatin-associated BAP1 [8,9] is completely ex-
tracted and separated from the insoluble material (IM). In response
to UV irradiation we observe a robust induction of a band at
100 kDa detected with the pS592-BAP1 antibody. In the NCI-H226
line there is a faint but reproducible signal at 100 kDa following
UV-treatment. Densitometry determined this signal to represent
1% of the signal observed in UV-treated HeLa. Our attempts to
immunoprecipitate (IP) phospho-BAP1 with this antibody recov-
ered BAP1, but LC–MS/MS showed it also precipitated p97/Vaso-
lin-containing protein (VCP) (unpublished observations). VCP is
an abundant protein that becomes phosphorylated at S784 follow-
ing DNA damage [19,23] and happens to co-migrate on SDS–PAGE
gels at the same position as BAP1. From this we conclude the
pS592-BAP1 has utility in immunoblots despite cross-reacting
with what is likely pS784-VCP to a much lesser extent.
To further assess whether the pS592-BAP1 antibody recognizes
phosphorylated BAP1, we performed IPs of BAP1 and HCF-1 from
endogenous HeLa SCEs (Fig. 1B). Consistent with previous reports
[5,8], BAP1 only brings down a small fraction of HCF-1, whileFig. 1. BAP1 is phosphorylated at S592 following UV irradiation. (A) The pS592-BAP1 an
BAP1-null NCI-H226 cells. Cells were mock/UV-treated with 1 mJ/cm2 and allowed to reco
of endogenous BAP1 and HCF-1 retrieves pS592-BAP1. Cells were mock- or UV irradi
Overexpressed Flag-HA-BAP1 is phosphorylated in the absence of UV. (D) The pS592-B
E, eluate; BA, boiled agarose). (E) Phospho-speciﬁcity of the pS592-BAP1 antibody.HCF-1 brings down a signiﬁcant fraction of BAP1. In the absence
of UV, there is no detectable pS592-signal in the IP inputs, yet after
UV-treatment the pS592-BAP1 signal is induced and both BAP1
and HCF-1 co-immunoprecipitate pS592-BAP1.
We next asked whether the pS592-BAP1 antibody recognizes
overexpressed BAP1. We transiently expressed Flag-HA-tagged
BAP1 and found it is phosphorylated in the absence of UV irradia-
tion (Fig. 1C). We conﬁrmed that the pS592-BAP1 signal corre-
sponds to exogenous BAP1, and not another protein of similar
mass induced by overexpression, by IP with anti-Flag agarose
(Fig. 1D). The speciﬁcity of the antibody for phospho-BAP1 was
conﬁrmed by treating SCEs of cells transiently expressing WT
BAP1 and a S592A mutant with calf intestinal phosphatase
(Fig. 1E). These studies demonstrate that UV irradiation induces
phosphorylation of S592, and the pS592-BAP1 antibody easily de-
tects endogenous levels of pS592-BAP1.
3.2. Phosphorylation of BAP1 at S592 occurs in S-phase following
UV irradiation
High doses of UV radiation, such as the 50 mJ/cm2 dose recom-
mended by the antibody manufacturer, are known to induce an
apoptotic response. Instead we sought to ﬁnd a UV-dose that in-
duced phosphorylation without causing cell death. We observed
a dose-dependent increase in pS592-BAP1 signal that plateaued at
a UV-dose of 25mJ/cm2 (Fig. 2A). To demonstrate that a 1 mJ/cm2
dose was not lethal, we assessed the cell cycle distribution of HeLa
cells at various times following UV treatment. Histograms of DNA
content (Supplementary Fig. 1) were analyzed with FlowJo soft-
ware to quantify cell cycle distributions. For 12 h following irradi-
ation cells progressed through G2-M and G1-phases but arrested intibody recognizes a 100 kDa band after UV-treatment in HeLa cells but not in the
ver 3 h before analyzing soluble cell extract (SCE) and insoluble material (IM). (B) IP
ated with a 50 mJ/cm2 dose and allowed to recover 2 h before IP from SCEs. (C)
AP1 signal is immunoprecipitated with anti-Flag agarose (In, Input; FT, Flow thru;
Fig. 2. BAP1 phosphorylation at S592 following UV-irradiation occurs in S-phase. (A) UV dose response of BAP1 phosphorylation in HeLa cells allowed to recover 3 h. (B) HeLa
cells resume proliferating after a 1 mJ/cm2 dose of UV and undergo minimal apoptosis. Cell cycle populations of HeLa cells at the indicated time following radiation (C) Cells
from (B) were analyzed for BAP1 and pS592-BAP1 levels. (D) Cell cycle analysis of HeLa cells released from a double thymidine block. (E) Cells from (D) were either mock- or
UV-treated at the indicated times and allowed to recover 1 h before harvesting.
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proliferating as the majority had completed S-phase. Importantly
the sub-G1 population, a measure of apoptotic cells, did not exceed
5% of the population.
The levels of BAP1 and pS592-BAP1 in these cells were exam-
ined by Western blotting. While BAP1 levels remained unchanged,
the pS592-BAP1 signal showed a strong correlation with cells in S-
phase (Fig. 2C). To better assess whether BAP1 is phosphorylated in
S-phase following irradiation with UV, we examined the induction
of pS592-BAP1 signal in cell populations within distinct cell cycle
phases. We used a double thymidine block to synchronize cells
in early S-phase, and collected cells every 2 h following release.
We observed a synchronous progression of cells out of S-phase,
through G2 and M-phases, and into G1-phase (Fig. 2D and Supple-
mentary Fig. 2). A parallel set of plates were irradiated with UV in
early-S (0 h), late-S (4 h), G2-M (8 h) and in G1 (12 h). Total BAP1
levels did not ﬂuctuate during the cell cycle in UV-damaged or un-
treated cells. The pS592-BAP1 signal, however, showed a maximal
induction when cells were in S-phase (Fig. 2E). From these studies
we conclude that BAP1 phosphorylation at S592 in HeLa following
UV irradiation occurs in S-phase and phosphorylation is lost upon
completion of replication.
3.3. BAP1 phosphorylated at S592 is predominately unassociated
with chromatin
We sought to monitor the localization of pS592-BAP1 as a func-
tion of time following irradiation with UV. We used differential
centrifugation and a non-ionic detergent to fractionate cells into
cytosolic (S1) and nuclear (P1) fractions [22]. We mock- or UV-
treated HeLa cells and allowed them to recover for various times
before separating into S1 and P1 fractions. Throughout the time
course, BAP1 and pS592 BAP1 are predominately localized in the
nucleus (Fig. 3A). A small portion of pS592-BAP1 is recovered in
the cytosolic fraction and this pool increase to a maximum at2 h, and decreases thereafter. As controls we reprobed these blots
with antibodies against Actin (loading), MEK1 (cytosolic), and
ubiquityl-Histone H2A (chromatin).
We further fractionated HeLa nuclei (S1) by lysing in a hypo-
tonic buffer to separate the nucleoplasmic proteins (S2) from chro-
matin-associated proteins (P2). In the nuclei of untreated cells, we
ﬁnd the majority of BAP1 is in the chromatin-containing P2 frac-
tion, while only a small amount appears in the S2 nucleoplasmic
fraction (Fig. 3B). Between 1 and 6 h, pS592-BAP1 appears largely
in the nucleoplasmic (S2) fraction while the signal originating from
the chromatin (P2) fraction peaks at 6 h. The pS592-BAP1 associ-
ated with chromatin could be completely eluted with 0.1 M NaCl,
while the majority of BAP1 eluted between 0.1 and 0.3 M NaCl
(Fig. 3C). Following UV irradiation we did not observe an increase
in the nucleoplasmic levels of known BAP1 binding partners HCF-1,
FoxK1, YY1, and ASXL1 as their chromatin elution proﬁles were
unperturbed. Thus, pS592-BAP1 binds much less tightly to chro-
matin than the dephosphorylated form.
The ﬁndings presented in Fig. 3B were also used to estimate the
fraction of total BAP1 that is phosphorylated at S592. Densitometry
was used to quantitate the bands in the BAP1 and pS592-BAP1
immunoblots. After 1 h we observe 95% of the pS592-BAP1 signal
in the S1 and S2 fractions, and this accounts for just 13% of the total
BAP1. This puts an upper limit of 13% of the total BAP1 that is phos-
phorylated. Collectively these ﬁndings support a model whereby
following irradiation with UV, chromatin-bound BAP1 in S-phase
cells is phosphorylated at S592 and this phospho-species dissoci-
ates from chromatin.
3.4. BAP1 is phosphorylated at S592 in response to DNA
replication stress
Having determined that BAP1 is phosphorylated in response to
UV irradiation, we next asked whether other forms of genotoxic
stress also elicit a similar response. Hydroxyurea (HU) is known
Fig. 3. BAP1 phosphorylated at S592 is not associated with chromatin. (A) pS592-BAP1 is predominately nuclear. Separation of HeLa cells into S1 (cytosolic) and P1 (nuclear)
fractions following 1 mJ/cm2 of UV radiation and recovery for the indicated times. (B) Nuclear pS592-BAP1 is predominately nucleoplasmic. HeLa nuclei were fractionated
into nucleoplasmic (S2) and chromatin-rich (P2) fractions at the indicated times following 1 mJ/cm2 of UV radiation. (C) pS592-BAP1 is weakly associated with chromatin.
Sequential extraction of a HeLa chromatin pellet with increasing concentrations of NaCl following a 1 mJ/cm2 UV dose and 3 h recovery.
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Replication stress can also be induced by methyl methanesulfonate
(MMS), an alkylating agent that methylates purine bases of DNA,
and oxidizing agents such as arsenite and hydrogen peroxide
(H2O2) which generate reactive oxygen species that react with
DNA bases. Each of these forms of stress was capable of inducing
phosphorylation, though to different extents (Fig. 4A). We ob-
served a similar level of induction of phosphorylation with UV,
HU, MMS and H2O2, while treatment with arsenite at levels known
to induce stress granule formation had a much weaker effect.
If replication stress induces phosphorylation of BAP1, we pre-
dict that prolonged exposure to HU (stalling an asynchronous cell
population in S-phase and at the G1/S boundary) would concomi-
tantly induce phosphorylation of BAP1. We treated HeLa cells with
HU and monitored cell cycle progression and pS592 levels as a
function of time. Cell cycle analysis found that cells in S-phase
immediately arrest, while cells in G2-M progressed into G1 and
stalled at the G1/S boundary along with G1 cells (Fig. 4B and Sup-
plementary Fig. 3). Assessing the protein levels in these cells
showed little variation in total BAP1 levels, but a steady increase
in pS592-BAP1 levels that reached a maximum at 24 h (Fig. 4C).
These ﬁnding support a model whereby replication stress is the
stimulus for BAP1 phosphorylation at S592.Our ﬁndings have demonstrated that BAP1 is phosphorylated at
S592 within a consensus ATM/ATR site following DNA damage and
replication stress. Phosphorylation at S592 is absent in unstressed
cells, yet is rapidly triggered to modify a small fraction of BAP1 in
S-phase of stressed cells. In contrast to the majority of BAP1 which
is chromatin-bound, pS592-BAP1 is predominately unassociated
with chromatin. These ﬁndings support a model whereby phos-
phorylation of BAP1 at S592 following DNA damage or stress pro-
motes its dissociation from chromatin. An alternative model,
where cytosolic and nucleoplasmic BAP1 become phosphorylated
at S592 to trigger chromatin association is less attractive for a
number of reasons. The majority of BAP1 is chromatin-bound
(Fig. 3B), and the kinase implicated under these stressors, ATR, is
activated by TOPBP1at sites of damage or stalled replication [25].
Thus, both the substrate and the active kinase reside largely on
chromatin. Additionally, the majority of the pS592-BAP1 signal is
unassociated with chromatin, even after 6 h (Fig. 3B), and chroma-
tin-bound pS592-BAP1 is more easily eluted from chromatin by
salt, suggesting it has a weaker afﬁnity for chromatin than unphos-
phorylated BAP1 (Fig. 3C).
Deﬁning the functional consequence of BAP1 phosphorylation
and dissociation from chromatin are beyond the scope of this
report. However two scenarios can be envisioned. In the ﬁrst,
Fig. 4. BAP1 is phosphorylated in response to DNA replication stress. (A) BAP1 is
phosphorylated in HeLa cells treated with UV, hydroxyurea (HU), methyl meth-
anesulfonate (MMS), arsenite (NaAsO2) and hydrogen peroxide (H2O2). (B) HeLa
cells arrest in S-phase and at the G1/S boundary following exposure to hydroxyurea.
(C) Cells from (B) were analyzed for BAP1 and pS592-BAP1 levels.
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mechanism that allows replication or repair machinery to access
DNA. In the second, BAP1 dissociation from or association with
chromatin could function in regulating the transcription of genes
involved in DNA replication or repair. In support of the latter mod-
el, a correlation between UV-dose and pS592-BAP1 levels was only
observed up to 25 mJ/cm2; higher UV-doses and additional damage
did not result in higher levels of pS592-BAP1 (Fig. 2A). Depletion of
BAP1 has been shown to alter the mRNA levels of several proteins,
including a subset that are involved in DNA replication and DNA
repair [11]. We found that only small fraction of BAP1 is phosphor-
ylated at S592 (Fig. 3B), a subset that we suspect regulates tran-
scription from these promoters. Loss of BAP1 would compromise
the cells ability to effectively repair the damage or halt cell cycle
progression in response to genotoxic stress.
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